Scilex Holding (SCLX) Current Assets (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Current Assets of $42.0 million for Q1 2026, up 46.22% year-over-year from $28.7 million in Q1 2025, and up 9.42% quarter-over-quarter from $38.4 million in Q4 2025.
Scilex Holding (SCLX) Current Assets (2020 - 2026) Analysis & Trends
Scilex Holding's Current Assets history runs 7 years deep, the most recent figure standing at $42.0 million for Q1 2026.
- In Q1 2026, Current Assets rose 46.22% year-over-year to $42.0 million; the TTM figure through Mar 2026 stood at $42.0 million (up 46.22% YoY), while the FY2025 annual figure was $38.4 million, down 7.68% from the prior year.
- Current Assets for Q1 2026 stood at $42.0 million, up from $38.4 million in the prior quarter.
- The five-year high for Current Assets was $69.2 million in Q2 2023, with the low at $165749.0 in Q3 2022.
- The 5-year median for Current Assets is $33.7 million (2025), against an average of $31.3 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets soared 15273.25% in 2023, then sank 58.63% in 2025.
- Scilex Holding's Current Assets stood at $29.6 million in 2022, then jumped by 58.0% to $46.8 million in 2023, then dropped by 11.19% to $41.5 million in 2024, then fell by 7.68% to $38.4 million in 2025, then gained by 9.42% to $42.0 million in 2026.
- Business Quant data shows SCLX's Current Assets at $42.0 million in Q1 2026, $38.4 million in Q4 2025, and $16.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.56 Bn | 632.80 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 469.72 Bn | 463.15 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 377.32 Bn | 370.18 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 302.80 Bn | 295.11 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 258.16 Bn | 253.26 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 237.16 Bn | 223.17 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 183.24 Bn | 180.06 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 160.63 Bn | 148.93 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Gsk | 106.06 Bn | 101.89 Bn | 8.24 Bn | 23.56 Bn |
| 10 | Scilex Holding | 40.64 Mn | -72.15 Mn | 3.97 Mn | 36.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.97 Mn |
| Dec 31, 2025 | 38.36 Mn |
| Sep 30, 2025 | 16.49 Mn |
| Jun 30, 2025 | 33.67 Mn |
| Mar 31, 2025 | 28.70 Mn |
| Dec 31, 2024 | 41.55 Mn |
| Sep 30, 2024 | 39.86 Mn |
| Jun 30, 2024 | 50.42 Mn |
| Mar 31, 2024 | 37.75 Mn |
| Dec 31, 2023 | 46.78 Mn |
| Sep 30, 2023 | 25.48 Mn |
| Jun 30, 2023 | 69.25 Mn |
| Mar 31, 2023 | 31.10 Mn |
| Dec 31, 2022 | 29.61 Mn |
| Sep 30, 2022 | 165,749.00 |
| Jun 30, 2022 | 612,848.00 |
| Mar 31, 2022 | 524,341.00 |
| Dec 31, 2021 | 23.00 Mn |
| Sep 30, 2021 | 232,178.00 |
| Jun 30, 2021 | 491,980.00 |